Free Trial

U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $109.00 Average Price Target from Brokerages

U.S. Physical Therapy logo with Medical background

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) has earned an average rating of "Buy" from the six ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $109.00.

A number of equities analysts have commented on USPH shares. JMP Securities reiterated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th.

Check Out Our Latest Stock Analysis on USPH

Insider Activity

In related news, Director Nancy Ham sold 400 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director now owns 2,594 shares in the company, valued at $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC boosted its position in U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in U.S. Physical Therapy by 952.4% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock worth $32,000 after purchasing an additional 400 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in U.S. Physical Therapy in the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC boosted its position in U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares in the last quarter. Finally, Fifth Third Bancorp boosted its position in U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after purchasing an additional 265 shares in the last quarter.

U.S. Physical Therapy Stock Down 1.4%

Shares of USPH stock traded down $1.06 on Wednesday, hitting $77.08. The stock had a trading volume of 362,464 shares, compared to its average volume of 116,821. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average price of $73.34 and a 200 day moving average price of $81.42. The company has a market cap of $1.17 billion, a PE ratio of 82.00, a P/E/G ratio of 3.54 and a beta of 1.45. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm's quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.51 earnings per share. Research analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were issued a dividend of $0.45 per share. The ex-dividend date was Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.34%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

U.S. Physical Therapy Company Profile

(Get Free Report

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines